Meeting Report: First International ISHAGE Symposium on Minimal Residual Cancer

ABSTRACT This conference was held on June 23–25, 1996, at the Kunstlerhaus, Munich, Germany, and was sponsored by the International Society for Hematotherapy and Graft Engineering, as well as AMGEN, Glaxo-Wellcome, Baxter, Becton Dickinson, Bristol-Myers-Squibb, Dynal, Essex Pharma, Lilly, Sandoz, BIS Laboratories, Boehringer Mannheim, CellPro, Centocor, Hoffmann LaRoche AG, Micromet/Labor fur Molekulare Onkologie, and Stem Cell Technologies, Inc. The conference was organized and cochaired by Drs. Klaus Pantel, Gert Riethmuller (Institute for Immunology, University of Munich, Munich, Germany), and Thomas J. Moss (Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA). Invited participants were R.C. Coombes (Charing Cross Hospital Medical School, London, United Kingdom), I. Diel (Uni Frauenklinik, Heidelberg, Germany), D. Dilloo (Department of Hematology/Oncology, St. Jude Medical Center, Memphis, TN), B. Dorken (Berlin, Germany), O. Fodstad (Norwegian Radium Hospital, Oslo, N...